MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5455/jpma.22016

Медицинская библиотека · JPMA. The Journal of the Pakistan Medical Association · 2020

Evaluation of HbA1c in type-2 diabetes mellitus patients with periodontitis: preliminary findings of three-arm clinical trial.

Peluso Rosario, Costa Luisa, Caso Francesco, Del Puente Antonio, Di Minno Matteo Nicola Dario, Manguso Francesco, Castiglione Fabiana, Scarpa Raffaele

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To assess a relationship and predict changes in glycaemic control due to chronic periodontitis in type-2 diabetic patients.

METHODS

Chronic periodontitis (CP) of a cross-section of 118 patients (age ?32 years) was determined using bleeding on probing (BOP), periodontal pocket depth (PPD) and clinical attachment loss (CAL). Their HbA1c, fasting blood glucose (FBG), fasting serum insulin (FSI) and homeostasis assessment model of insulin resistance (HOMA-IR) levels were also tested. Stata 11.0 was used to assess correlation between periodontal and glycaemic measures. Univariate analysis followed by multiple regression analysis through stepwise forward selection process was used to explore significant variables that may predict change in HbA1c. Multi-collinearity and heteroskedasticity were assessed at p-value > 0.05.

RESULTS

Results of participants (n=95) showed significantly positive correlations (r) between HbA1c and BOP [r = 0.34, p-value = 0.002], PPD [r = 0.36, p-value = 0.003] and CAL [r=0.42, p-value = 0.002]. However, FBG and HOMA-IR were not found correlated with any of the periodontal measures; except CAL with FBG [r=0.27, p-value=0.02]. In addition to healthy controlled diet, cultural background, education and FBG, CAL was found significant [coef. = 0.746, p-value = 0.001, CI = 0.339, 1.153] to predict change in HbA1c in the final model [R2 = 0.549, p-value < 0.001] with no multicollinearity [mean VIF =1.30] and heteroskedasticity [chi 2 =0.02, p-value= 0.878] in fi n al model.

CONCLUSIONS

Increased CAL is estimated to increase HbA1c level by 0.75% in T2DM patients after controlling other factors. It is suggested that periodontal prophylactic management may be planned with an aim to reduce HbA1c.

CLINICAL TRIAL REGISTRATION NO: NCT03343366.

Для цитирования: Peluso Rosario, Costa Luisa, Caso Francesco, Del Puente Antonio, Di Minno Matteo Nicola Dario, Manguso Francesco, Castiglione Fabiana, Scarpa Raffaele. Evaluation of HbA1c in type-2 diabetes mellitus patients with periodontitis: preliminary findings of three-arm clinical trial.. JPMA. The Journal of the Pakistan Medical Association. 2020. DOI: 10.5455/jpma.22016.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.